Despite having a reputation of low virulence, Acinetobacter baumannii is an emerging
multidrug-resistant (MDR) pathogen responsible for community-and hospital-acquired …

The emergence and spread of carbapenemase-producing bacteria, that hydolyze most β-
lactams, including carbapenems, are a major concern of public health system worldwide …

Background Acinetobacter calcoaceticus–A. baumannii (Acb) complex and
Stenotrophomonas maltophilia represent frequent causes of hospital-acquired infections …

Metallo-b-lactamase (MBL)-producing Acinetobacter baumannii has become a growing
therapeutic concern worldwide. The aims of this study were to evaluate the antimicrobial …

Carbapenem-resistant Acinetobacter baumannii (CRAB) are an increasing infectious threat
in hospitals. We investigated the clinical epidemiology of CRAB infections vs. colonization in …

OBJECTIVES: The incidence of multi-drug-resistant (MDR) Acinetobacter strains is
increasing and therapeutic options are limited. However, controversy exists regarding the …

Background Acinetobacter baumannii has successfully become a significant nosocomial
pathogen because of its remarkable ability to acquire antibiotic resistance and to survive in …

Background The consumption of carbapenems has increased worldwide, together with the
increase in resistant gram negative bacilli. Subsequently, the prevalence of carbapenem …

This study reports the dissemination of multidrug-resistant (MDR) OXA-23-producing
Acinetobacter baumannii clones in hospitals in Antananarivo, Madagascar. A total of 53 …

Objectives Infections caused by multidrug-resistant (MDR) Acinetobacter baumannii are a
challenging problem worldwide. Here, the molecular epidemiology and the genetic basis of …